(Q73883280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Fexofenadine-induced QT prolongation: a myth or fact? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

P K Hazra

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Malakar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G Mistri

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1260-1261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03576.X

Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03576.X

Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03576.X

Mechanism of the cardiotoxic actions of terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03576.X

QT lengthening and life-threatening arrhythmias associated with fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03576.X

Cardiovascular safety of fexofenadine HCl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03576.X

Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03576.X

Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2000.03576.X

10.1046/J.1365-2133.2000.03576.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10848773%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference